Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexxar/BEAM vs Rituxan/BEAM in Relapsed DLBCL
NCT00329030Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Dec 2005
- Primary completion
- Aug 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of tositumomab in diffuse large B-cell lymphoma (DLBCL), sponsored by National Heart, Lung, and Blood Institute. Started Dec 2005; status: completed.
02
Drugs
tositumomab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00329030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00329030.